Drip Portfolio Report
Wednesday, September 24, 1997
by Jeff Fischer (TMF Jeff@aol.com)
ALEXANDRIA, VA (Sept. 24, 1997) -- Well, thanks to either America Online, Dell Computer, Intel, Cisco Systems, Lucent, or some other giant corporation, this single computer that I work on crashed at 7:15pm and I lost the entire recap. Rather than try to throw together something half-baked in time for the 7:30 deadline, we'll (or I mean, I'll) rewrite the column tomorrow.
Guess what. Tomorrow we're going to cover -- woohoo! -- ABBOTT LABORATORIES (NYSE: ABT), the third-largest of our four healthcare considerations. Abbott has a wonderful Web site at www.abbott.com. If you're interested in the company, take a look. Remember that Schering-Plough and Pfizer have product mixes that are 90% and 72% pharmaceuticals, respectively. Read, good Fools, about Abbott's business and study the financials to learn what it did to score $11 billion in sales in 1996.
We'll compare Abbott's business to our other considerations, but mainly to PFIZER (NYSE: PFE) because between Schering-Plough and Pfizer we have, as we said, sided with the business of Pfizer.
Hope your computer holds up. Be careful. The online world is a jungle sometimes. Our Foolish apologies. Perhaps the valuing 3Com article can fill in tonight.
More from The Motley Fool
6 Ways to Make Your Retirement Savings Last
Breaking a big retirement rule is one of them.
Can You Really Make Money Mining Bitcoins?
Profits are not easy to come by. Expensive hardware and risky cloud mining deals are the main challenges.
3 Things to Watch in the Stock Market This Week
Look for Netflix, P&G, and Starbucks to make big moves over the next few trading days.